Browsing Tag
ICICI Securities
18 posts
India’s aluminium recycling boom is coming to Dalal Street. CMR Green Technologies is the test case
CMR Green Technologies IPO brings India’s aluminium recycling story to Dalal Street, but the pure OFS structure raises a key investor question.
Why India Inc’s FY27 spending plan may be bigger than another infrastructure headline
India Inc is shifting FY27 capex toward defence, energy, metals and AI infrastructure. Read how this could reshape market leadership.
Royal Enfield posts 31% April surge as Eicher Motors steadies near Rs 7,275 ahead of May 8 Q4 print (NSE: EICHERMOT)
Royal Enfield just posted its biggest April ever. Q4 results land Thursday. The market is pricing one and ignoring the other.
NTPC just hit record capacity additions, signed a nuclear deal with France and still trades at a discount. Worth watching?
NTPC (NSE: NTPC) hit record FY26 capacity additions and signed an EDF nuclear MoU. With ₹380 CMP and analyst targets to ₹440, here is what retail investors need to know.
TCS Q4 FY26 results: Profit up 12%, record $40.7bn deal wins and AI revenue cross $2.3bn
TCS Q4 FY26 results beat expectations with ₹13,718 crore profit, $12bn TCV and $2.3bn annualised AI revenue. What it means for NSE retail investors watching the stock.
ICICIBANK at Rs 1,310: 38 analysts say buy. April 18 decides.
ICICI Bank (NSE: ICICIBANK) Q4 FY26 results on April 18. PAT consensus ₹11,500 to 12,200 Cr. Analyst targets up to ₹2,040. Key risks, iMobile Pay, and dividend outlook covered.
Ganesha Ecosphere (GANECOS): India’s rPET mandate kicks in and the stock has already moved 42%
India's largest PET bottle recycler hit the upper circuit on April 1, 2026, the day the government's mandatory 40% recycled content rule for food-contact packaging took effect. GANECOS has gained more than 42% in four sessions from a 52-week low. The next question for investors is whether the regulatory tailwind translates into earnings recovery, or whether the stock has already priced in most of the good news.
Why Indegene’s BioPharm acquisition could become the blueprint for AI-first commercialization models in pharma
Discover how Indegene’s $104 million acquisition of BioPharm is setting a new paradigm in AI-driven precision pharma marketing.
Can Infra.Market’s Rs 5,000cr IPO turn India’s construction boom into a stock market play?
Infra.Market files Rs 5,000 crore IPO via confidential route. Find out how the building materials marketplace is reshaping India’s infrastructure story.
Indian Oil stock: why ICICI Securities says it’s still a buy despite margin pressures
ICICI Securities maintains ‘Buy’ on Indian Oil (NSE: IOC), citing valuation comfort, dividend yield, and medium-term growth prospects. See the outlook.